Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: A systematic review and meta-analysis

European Journal of Endocrinology

Volumn 168, Issue 6, 2013, Pages 829-843

  Corona, Giovanni ^a,b   Rastrelli, Giulia ^a   Monami, Matteo ^c   Saad, Farid ^d   Luconi, Michaela ^c   Lucchese, Marcello ^c   Facchiano, Enrico ^c   Sforza, Alessandra ^b   Forti, Gianni ^c   Mannucci, Edoardo ^e   Maggi, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Azienda USL di Bologna   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d BAYER PHARMA AG   (Germany)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; SEX HORMONE; SEX HORMONE BINDING PROTEIN; TESTOSTERONE;

AEROBIC EXERCISE; AGE DISTRIBUTION; ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; DIABETES MELLITUS; DIET THERAPY; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; FOLLOW UP; GASTROPLASTY; GONADOTROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INTERMETHOD COMPARISON; LOW CALORY DIET; LOW FAT DIET; MEDLINE; META ANALYSIS; MORBID OBESITY; OBESITY ASSOCIATED HYPOGONADOTROPIC HYPOGONADISM; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN DIET; RESISTANCE TRAINING; SYSTEMATIC REVIEW; TESTOSTERONE BLOOD LEVEL; WEIGHT REDUCTION;

BODY WEIGHT; HUMANS; HYPOGONADISM; OBESITY; WEIGHT LOSS;

EID: 84878715496     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0955     Document Type: Article

References (70)

1. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011 377 557-567. (doi:10.1016/S0140-6736(10)62037-5)
2. Corona G, Lee DM, Forti G, O'Connor DB, Maggi M, O'Neill TW, Pendleton N, Bartfai G, Boonen S, Casanueva FF et al. Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). Journal of Sexual Medicine 2010 1 1362-1380. (doi:10.1111/j.1743-6109.2009.01601.x)
3. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ & the Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002 360 1347-1360. (doi:10.1016/S0140-6736(02)11403-6) (Pubitemid 35341298)
4. Ni Mhurchu C, Rodgers A, Pan WH, Gu DF & Woodward M. Body mass index and cardiovascular disease in the Asia-Pacific region: an overview of 33 cohorts involving 310 000 participants. International Journal of Epidemiology 2004 33 751-758. (doi:10.1093/ije/dyh163) (Pubitemid 39263851)
5. Prospective Studies Collaboration. Body-mass index and causespecific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009 373 1083-1096. (doi:10.1016/S0140-6736(09)60318-4)
6. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization, 2009.
7. Corona G, Monami M, Boddi V, Balzi D, Melani C, Federico N, Balzi D, Sforza A, Rotella CM, Forti G et al. Is obesity a further cardiovascular risk factor in patients with erectile dysfunction? Journal of Sexual Medicine 2010 7 2538-2546.
8. Corona G, Monami M, Boddi V, Cameron-Smith M, Lotti F, de Vita G, Melani C, Balzi D, Sforza A, Forti G et al. Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. Journal of Sexual Medicine 2010 7 1918-1927. (doi:10.1111/j.1743-6109.2010.01744.x)
9. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 2001 344 1343-1350. (doi:10.1056/ NEJM200105033441801) (Pubitemid 32378388)
10. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM & Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 2002 346 393-403. (doi:10.1056/NEJMoa012512) (Pubitemid 34437694)
11. Yamaoka K & Tango T. Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 2005 28 2780-2786. (doi:10.2337/diacare.28.11.2780) (Pubitemid 43951177)
12. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT & Khunti K. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007 334 29912-29915. (doi:10.1136/bmj.39063.689375.55) (Pubitemid 46293963)
13. Bray GA. Uses and misuses of the new pharmacotherapy of obesity. Annals of Medicine 1999 31 1-3. (doi:10.3109/07853899909019257) (Pubitemid 29134480)
14. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP & Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. American Journal of Medicine 2009 122 248-256. (doi:10.1016/j.amjmed.2008.09.041)
15. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. New England Journal of Medicine 2012 366 1577-1585. (doi:10.1056/NEJMoa1200111)
16. Dixon JB, Schachter LM, O'Brien PE, Jones K, Grima M, Lambert G, Brown W, Bailey M & Naughton MT. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. Journal of the American Medical Association 2012 308 1142-1149. (doi:10.1001/2012.jama. 11580)
17. Maciejewski ML, Livingston EH, Smith VA, Kavee AL, Kahwati LC, Henderson WG & Arterburn DE. Survival among high-risk patients after bariatric surgery. Journal of the American Medical Association 2011 305 2419-2426. (doi:10.1001/jama.2011.817)
18. Himpens J, Cadière GB, Bazi M, Vouche M, Cadière B & Dapri G. Long-term outcomes of laparoscopic adjustable gastric banding. Archives of Surgery 2011 146 802-807. (doi:10.1001/archsurg.2011.45)
19. Corona G, Rastrelli G, Forti G & Maggi M. Update in testosterone therapy for men. Journal of Sexual Medicine 2011 8 639-654. (doi:10.1111/j.1743- 6109.2010.02200.x)
20. Corona G, Rastrelli G, Vignozzi L & Maggi M. Emerging medication for the treatment of male hypogonadism. Expert Opinion on Emerging Drugs 2012 17 239-592. (doi:10.1517/14728214.2012.683411)
21. Corona G, Rastrelli G, Vignozzi L, Mannucci E & Maggi M. How to recognize late-onset hypogonadism in men with sexual dysfunction. Asian Journal of Andrology 2012 14 251-259. (doi:10.1038/aja.2011.138)
22. Corona G, Rastrelli G, Morelli A, Vignozzi L, Mannucci E & Maggi M. Hypogonadism and metabolic syndrome. Journal of Endocrinological Investigation 2011 34 557-567.
23. Corona G, Mannucci E, Forti G & Maggi M. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? International Journal of Andrology 2009 32 431-441. (doi:10.1111/j.1365-2605.2009.00965.x)
24. Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A et al. Hypothalamic-pituitary- testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. Journal of Clinical Endocrinology and Metabolism 2008 93 2737-2745. (doi:10.1210/jc.2007-1972) (Pubitemid 352008544)
25. Saad F, Aversa A, Isidori AM & Gooren LJ. Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review. Current Diabetes Reviews 2012 8 131-143. (doi:10.2174/ 157339912799424573)
26. Stanik S, Dornfeld LP, Maxwell MH, Viosca SP & Korenman SG. The effect of weight loss on reproductive hormones in obese men. Journal of Clinical Endocrinology and Metabolism 1981 53 828-832. (doi:10.1210/jcem-53-4-828) (Pubitemid 13238668)
27. Hoffer LJ, Beitins IZ, Kyung NH & Bistrian BR. Effects of severe dietary restriction on male reproductive hormones. Journal of Clinical Endocrinology and Metabolism 1986 62 288-292. (doi:10.1210/jcem-62-2-288) (Pubitemid 16121556)
28. Pasquali R, Casimirri F, Melchionda N, Fabbri R, Capelli M, Platè L, Patrono D, Balestra V & Barbara L. Weight loss and sex steroid metabolism in massively obese man. Journal of Endocrinological Investigation 1988 11 205-210.
29. Strain GW, Zumoff B, Miller LK, Rosner W, Levit C, Kalin M, Hershcopf RJ & Rosenfeld RS. Effect of massive weight loss on hypothalamic-pituitary- gonadal function in obese men. Journal of Clinical Endocrinology and Metabolism 1988 66 1019-1023. (doi:10.1210/jcem-66-5-1019)
30. Pritchard J, Després JP, Gagnon J, Tchernof A, Nadeau A, Tremblay A & Bouchard C. Plasma adrenal, gonadal, and conjugated steroids following long-term exercise-induced negative energy balance in identical twins. Metabolism 1999 48 1120-1127. (doi:10.1016/S0026-0495(99)90125-7) (Pubitemid 29418281)
31. Kaukua J, Pekkarinen T, Sane T & Mustajoki P. Sex hormones and sexual function in obese men losing weight. Obesity Research 2003 11 689-694. (doi:10.1038/oby.2003.98) (Pubitemid 41151594)
32. Niskanen L, Laaksonen DE, Punnonen K, Mustajoki P, Kaukua J & Rissanen A. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome. Diabetes, Obesity & Metabolism 2004 6 208-215. (doi:10.1111/j.1462-8902.2004.00335.x) (Pubitemid 38559701)
33. Heufelder AE, Saad F, Bunck MC & Gooren L. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. Journal of Andrology 2009 30 726-733. (doi:10.2164/jandrol.108.007005)
34. Khoo J, Piantadosi C, Worthley S & Wittert GA. Effects of a lowenergy diet on sexual function and lower urinary tract symptoms in obese men. International Journal of Obesity 2010 34 1396-1403. (doi:10.1038/ijo.2010.76)
35. Reis LO, Favaro WJ, Barreiro GC, de Oliveira LC, Chaim EA, Fregonesi A & Ferreira U. Erectile dysfunction and hormonal imbalance in morbidly obese male is reversed after gastric bypass surgery: a prospective randomized controlled trial. International Journal of Andrology 2010 33 736-744. (doi:10.1111/j.1365-2605.2009.01017.x)
36. Leenen R, van der Kooy K, Seidell JC, Deurenberg P & Koppeschaar HP. Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. Journal of Clinical Endocrinology and Metabolism 1994 78 1515-1520. (doi:10.1210/jc.78.6.1515) (Pubitemid 24181029)
37. Kraemer WJ, Volek JS, Clark KL, Gordon SE, Puhl SM, Koziris LP, McBride JM, Triplett-McBride NT, Putukian M, Newton RU et al. Influence of exercise training on physiological and performance changes with weight loss in men. Medicine and Science in Sports and Exercise 1999 31 1320-1329. (doi:10.1097/00005768-199909000-00014) (Pubitemid 29424652)
38. Volek JS, Sharman MJ, Love DM, Avery NG, Gómez AL, Scheett TP & Kraemer WJ. Body composition and hormonal responses to a carbohydrate-restricted diet. Metabolism 2002 51 864-870. (doi:10.1053/meta. 2002.32037) (Pubitemid 34784812)
39. Khoo J, Piantadosi C, Duncan R, Worthley SG, Jenkins A, Noakes M, Worthley MI, Lange K & Wittert GA. Comparing effects of a low-energy diet and a high-protein low-fat diet on sexual and endothelial function, urinary tract symptoms, and inflammation in obese diabetic men. Journal of Sexual Medicine 2011 10 2868-2875. (doi:10.1111/j.1743-6109.2011.02417.x)
40. Klibanski A, Beitins IZ, Badger T, Little R & McArthur JW. Reproductive function during fasting in men. Journal of Clinical Endocrinology and Metabolism 1981 53 258-263. (doi:10.1210/jcem-53-2-258) (Pubitemid 13250280)
41. Bastounis EA, Karayiannakis AJ, Syrigos K, Zbar A, Makri GG & Alexiou D. Sex hormone changes in morbidly obese patients after vertical banded gastroplasty. European Surgical Research 1998 30 43-47. (doi:10.1159/000008556) (Pubitemid 28048519)
42. Globerman H, Shen-Orr Z, Karnieli E, Aloni Y & Charuzi I. Inhibin B in men with severe obesity and after weight reduction following gastroplasty. Endocrine Research 2005 31 17-26. (doi:10.1080/07435800500228971) (Pubitemid 41419981)
43. Alagna S, Cossu ML, Gallo P, Tilocca PL, Pileri P, Alagna G, Maninchedda P, Sini AL, Pilo L, Rovasio PP et al. Biliopancreatic diversion: long-term effects on gonadal function in severely obese men. Surgery for Obesity and Related Diseases 2006 2 82-86. (doi:10.1016/j.soard.2006.01.005)
44. Hammoud A, Gibson M, Hunt SC, Adams TD, Carrell DT, Kolotkin RL & Meikle AW. Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. Journal of Clinical Endocrinology and Metabolism 2009 94 1329-1332. (doi:10.1210/jc.2008-1598)
45. Omana JJ, Tamler R, Strohmayer E, Herron D & Kini S. Sex hormone levels in men undergoing bariatric surgery. Journal of the American College of Surgeons 2009 35 S22-S23. (doi:10.1016/j.jamcollsurg.2009.06.042)
46. Botella-Carretero JI, Balsa JA, Gómez-Martin JM, Peromingo R, Huerta L, Carrasco M, Arrieta F, Zamarron I, Martin-Hidalgo A & Vazquez C. Circulating free testosterone in obese men after bariatric surgery increases in parallel with insulin sensitivity. Journal of Endocrinological Investigation 2013. In press.
47. Facchiano E, Scaringi S, Veltri M, Samavat J, Maggi M, Forti G, Luconi M & Lucchese M. Age as a predictive factor of testosterone improvement in male patients after bariatric surgery: preliminary results of a monocentric prospective study. Obesity Surgery 2012 23 167-172. (doi:10.1007/s11695-012- 0753-6)
48. Pellitero S, Olaizola I, Alastrue A, Martínez E, Granada ML, Balibrea JM, Moreno P, Serra A, Navarro-Díaz M, Romero R et al. Hypogonadotropic hypogonadism in morbidly obese males is reversed after bariatric surgery. Obesity Surgery 2012 22 1835-1842.
49. Eds Higgins JPT & Green S. In Cochrane Handbook for Systematic Reviews of Interventions, version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008. (Available from www.cochrane-handbook.org).
50. Woodard G, Ahmed S, Podelski V, Hernandez-Boussard T, Presti J Jr & Morton JM. Effect of Roux-en-Y gastric bypass on testosterone and prostate-specific antigen. British Journal of Surgery 2012 99 693-698. (doi:10.1002/bjs.8693)
51. Giagulli VA, Kaufman JM & Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. Journal of Clinical Endocrinology and Metabolism 1994 79 997-1000. (doi:10.1210/jc.79.4.997) (Pubitemid 24342237)
52. Vermeulen A, Kaufman JM, Deslypere JP & Thomas G. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. Journal of Clinical Endocrinology and Metabolism 1993 76 1140-1146. (doi:10.1210/jc.76.5.1140) (Pubitemid 23155426)
53. Corona G, Mannucci E, Fisher AD, Lotti F, Petrone L, Balercia G, Bandini E, Forti G & Maggi M. Low levels of androgens in men with erectile dysfunction and obesity. Journal of Sexual Medicine 2008 5 2454-2463.
54. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A & Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2004 89 5462-5468. (doi:10.1210/jc.2004-0804) (Pubitemid 39518427)
55. Dandona P & Dhindsa S. Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. Journal of Clinical Endocrinology and Metabolism 2011 96 2643-2651. (doi:10.1210/jc.2010-2724)
56. Saad F, Aversa A, Isidori AM, Zafalon L, Zitzmann M & Gooren L. Onset of effects of testosterone treatment and time span until maximum effects are achieved. European Journal of Endocrinology 2011 165 675-685. (doi:10.1530/EJE-11-0221)
57. Loves S, Ruinemans-Koerts J & de Boer H. Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism. European Journal of Endocrinology 2008 158 741-747. (doi:10.1530/EJE-07-0663) (Pubitemid 351639613)
58. Michalakis K, Mintziori G, Kaprara A, Tarlatzis BC & Goulis DG. The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review. Metabolism 2013. In press. (doi:10.1016/j.metabol.2012.08. 012)
59. Burcelin R, Thorens B, Glauser M, Gaillard RC & Pralong FP. Gonadotropin-releasing hormone secretion from hypothalamic neurons: stimulation by insulin and potentiation by leptin. Endocrinology 2003 144 4484-4491. (doi:10.1210/en.2003-0457) (Pubitemid 37204848)
60. Corona G, Mannucci M, Petrone L, Ricca V, Balercia G, Mansani R, Chiarini V, Giommi R, Forti G & Maggi M. Association of hypogonadism and type 2 diabetes in men attending an outpatient erectile dysfunction clinic. International Journal of Impotence Research 2006 18 190-197. (doi:10.1038/sj.ijir.3901391) (Pubitemid 43336487)
61. Brüning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Mü ller-Wieland D & Kahn CR. Role of brain insulin receptor in control of body weight and reproduction. Science 2000 289 2122-2125. (doi:10.1126/science.289.5487.2122)
62. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM, Task Force & Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2010 95 2536-2559. (doi:10.1210/jc.2009-2354)
63. Buvat J, Maggi M, Gooren L, Guay AT, Kaufman J, Morgentaler A, Schulman C, Tan HM, Torres LO, Yassin A et al. Endocrine aspects of male sexual dysfunctions. Journal of Sexual Medicine 2010 7 (4 Pt 2) 1627-1656. (doi:10.1111/j.1743-6109.2010.01780.x)
64. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B et al. Effects of bariatric surgery on mortality in Swedish obese subjects. New England Journal of Medicine 2007 357 741-752. (doi:10.1056/NEJMoa066254) (Pubitemid 47295641)
65. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. New England Journal of Medicine 2004 351 2683-2693. (doi:10.1056/NEJMoa035622) (Pubitemid 39665322)
66. Corona G, Rastrelli G, Monami M, Guay A, Buvat J, Sforza A, Forti G, Mannucci E & Maggi M. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. European Journal of Endocrinology 2011 165 687-701. (doi:10.1530/EJE-11-0447)
67. Corona G, Monami M, Rastrelli G, Aversa A, Sforza A, Lenzi A, Forti G, Mannucci E & Maggi M. Type 2 diabetes mellitus and testosterone: a meta-analysis study. International Journal of Andrology 2011 34 (6 Pt 1) 528-540. (doi:10.1111/j.1365-2605.2010.01117.x)
68. Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F, LenziA, Forti G,Mannucci E &MaggiM. Testosterone andmetabolic syndrome: a meta-analysis study. Journal of Sexual Medicine 2011 8 272-283. (doi:10.1111/j.1743-6109.2010.01991.x)
69. Hoyos CM, Yee BJ, Phillips CL, Machan EA, Grunstein RR & Liu PY. Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnea: a randomised placebo-controlled trial. European Journal of Endocrinology 2012 167 531-541. (doi:10.1530/EJE-12-0525)
70. Mingrone G, Greco AV, Giancaterini A, Scarfone A, Castagneto M & Pugeat M. Sex hormone-binding globulin levels and cardiovascular risk factors in morbidly obese subjects before and after weight reduction induced by diet or malabsorptive surgery. Atherosclerosis 2002 161 455-462. (doi:10.1016/S0021- 9150(01)00667-0) (Pubitemid 34219201)